REGISTERED
on 08 Oct 2019
Last Applicant/ Owned by
1 place Pierre Potier, Oncopole entree B
Toulouse Cedex 1
FR
BP50624
Serial Number
86835146 filed on 01st Dec 2015
Registration Number
5876999 registered on 08th Oct 2019
Correspondent Address
Jeffrey M. Goehring
Filing Basis
1. intent to use
Disclaimer
NO DATA
GAMAMABS
Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endome Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Chemical, biological and pharmaceutical research and development in the field of cancers and other proliferative diseases; conducting clinical trials for others in the field of cancers and other proliferative diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Drug delivery devices, namely, drug delivery systems; injection devices for pharmaceutical preparations for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease; diagnostic devices, namely, biosensor analyzers for detecting cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, medical imaging apparatus for diagnosing cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, immunoanalyzers, namely, immunochemical testing equipment for medical use; medical testing equipment in the nature of medical instruments for analyzing and identifying bacteria in the nature of bacteriologic analyzers, for manual or for automated analysis for use in measuring or testing of biological samples in medical and clinical applications for the treatment of cancers and other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancers and pharmaceutical preparations for the treatment of other proliferative diseases, namely, pharmaceuticals for the treatment of endometriosis, pharmaceuticals for the treatment of Polycystic Ovary Syndrome and pharmaceuticals for the treatment of tubal disease; monoclonal antibodies for the treatment of cancers and monoclonal antibodies for the treatment of other proliferative diseases, namely, endometriosis, Polycystic Ovary Syndrome and tubal disease, gene expression profiles or other molecular indicators or markers, namely, nucleic acid sequences and chemical reagents for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 86835146
Mark Type
No Service Mark
Attorney Docket Number
No 7259-0004
44D Filed
No
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Oct 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 23rd Mar 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Mar 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 23rd Mar 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 23rd Mar 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 08th Oct 2019 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Jul 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Jul 2019 | PUBLISHED FOR OPPOSITION |
| 03rd Jul 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 19th Jun 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |